| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |